Dashboard
Manage Tickers

CLBS


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-vintage-wine-estates-shares-tumbled-40-here-are-70-biggest-movers-from-yesterday
Why Vintage Wine Estates Shares Tumbled 40...
09/15/2022 09:21:04

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resu...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
09/14/2022 17:33:47

 

stocks-that-hit-52-week-lows-on-wednesday
Stocks That Hit 52-Week Lows On Wednesday
09/14/2022 16:30:24

  During Wednesday's session, 265 companies made new 52-week lows.

why-scisparc-is-trading-higher-by-68-here-are-48-stocks-moving-in-wednesdays-mid-day-session
Why SciSparc Is Trading Higher By 68%, Her...
09/14/2022 16:28:41

Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.

Core News & Articles
Ten Stocks Trending on Discord for Wednesd...
09/14/2022 14:09:46

caladrius-biosciences-announces-approval-of-merger-and-name-change-to-lisata-therapeutics
Caladrius Biosciences Announces Approval O...
09/14/2022 12:11:28

BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the &...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
09/02/2022 12:07:30

 

why-pagerduty-is-trading-higher-by-9-here-are-28-stocks-moving-premarket
Why Pagerduty Is Trading Higher By 9%; Her...
09/02/2022 10:26:22

Gainers

biotech-daily-cancer-causing-impurities-in-mercks-diabetic-drug-vir-bio-gsk-shun-fda-submission-plans-for-covid-19-treatment-aethlons-monkeypox-trial
Biotech Daily: Cancer Causing Impurities I...
08/10/2022 15:33:07

Here's a roundup of top developments in the biotech space over the last 24 hours:

caladrius-biosciences-prospective-merger-partner-cend-therapeutics-announces-collaboration-agreement-with-roche-to-evaluate-cend-1-in-combination-with-immunotherapy-to-treat-pancreatic-cancer
Caladrius Biosciences' Prospective Merger ...
08/10/2022 12:03:07

Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company") and Cend Therapeutics, Inc. ("Cend...

caladrius-biosciences-q2-eps-011-misses-010-estimate
Caladrius Biosciences Q2 EPS $(0.11) Misse...
08/04/2022 21:39:15

Caladrius Biosciences (NASDAQ:CLBS) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate ...

earnings-scheduled-for-august-4-2022
Earnings Scheduled For August 4, 2022
08/04/2022 08:23:01

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.

earnings-outlook-for-caladrius-biosciences
Earnings Outlook For Caladrius Biosciences
08/03/2022 17:18:26

Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's wha...

caladrius-biosciencess-earnings-outlook
Caladrius Biosciences's Earnings Outlook
08/03/2022 17:17:28

Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's wha...

recap-of-tuesdays-biotech-catalysts---end-of-the-day-summary
Recap Of Tuesday's Biotech Catalysts - End...
08/02/2022 22:39:58

caladrius-biosciences-completes-enrollment-in-phase-1b-study-of-clbs201-for-the-treatment-of-diabetic-kidney-disease
Caladrius Biosciences Completes Enrollment...
08/02/2022 12:03:07

Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmaceutical co...

caladrius-biosciences-and-cend-therapeutics-highlights-publication-of-pancreatic-cancer-trial-data-in-the-lancet-gastroenterology-and-hepatology
Caladrius Biosciences And Cend Therapeutic...
07/06/2022 12:03:46

Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmaceutical co...

caladrius-biosciences-inc-ma-partner-cend-therapeutics-announces-first-patient-treated-in-phase-2b-trial-of-cend-1-led-by-australasian-gastro-intestinal-trials-group
Caladrius Biosciences, Inc. M&A Partner Ce...
06/09/2022 12:09:17

SAN DIEGO, June 09, 2022 (GLOBE NEWSWIRE) -- Cend Therapeutics, Inc. ("Cend") today announced that the first patient ha...

the-daily-biotech-pulse-inmune-bios-planned-alzheimers-trial-on-fda-hold-caladrius-stops-enrollment-in-heart-disease-study-biomx-restructures
The Daily Biotech Pulse: INmune Bio's Plan...
05/24/2022 12:24:46

Here's a roundup of top developments in the biotech space over the last 24 hours:

caladrius-biosciences-stops-enrollment-in-mid-stage-heart-disease-study
Caladrius Biosciences Stops Enrollment In ...
05/24/2022 09:48:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION